MAiDATA

Use case

Compare brands and market shares

Compare brands and market shares

Compare brands and market shares

See how brands and generics within a molecule or ATC group are performing over time.

4 min read

Comparing brands is one of the most common questions brand and market access teams ask.

Start with the molecule

Compare all rivaroxaban brands by package count and reimbursement for 2023 to 2025 and calculate their market shares.

Look at the whole group

Show the top 10 molecules in ATC group N05A by reimbursement in 2025.

See who leads

Which marketing-authorisation holders lead the denosumab market in 2025?

Keep in mind

  • Reimbursement is what public health insurance paid, not the manufacturer’s revenue.

  • The data covers reimbursed products only.

  • The most recent year is usually partial, so compare full years or equal periods.